← Back to Search

Procedure

Ommaya Reservoir Placement for Brain Cancer

N/A
Recruiting
Led By Terry C Burns, MD, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing to undergo neurosurgical resection at Mayo Clinic (Rochester, MN)
Age > 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, approximately 42 days
Awards & highlights

Study Summary

This trial will test whether it is safe to place a medical device called an Ommaya reservoir during surgery for brain tumors. The device will be used to study potential biomarkers for brain tumors.

Who is the study for?
Adults over 18 with a suspected or diagnosed brain tumor who are undergoing surgery at Mayo Clinic in Rochester, MN. Participants must be willing to sign consent forms and allow their cerebrospinal fluid (CSF) to be collected for research. Pregnant women, prisoners, minors, those not fit for surgery due to medical history or illness, and individuals with infection risks like diabetes or smoking are excluded.Check my eligibility
What is being tested?
The trial is testing the safety of placing an Ommaya Reservoir into the brain during tumor removal surgery. This device will provide ongoing access to CSF for biomarker analysis and monitoring throughout the treatment process.See study design
What are the potential side effects?
Potential side effects may include complications from surgery such as infection risk around the reservoir site, possible immune system reactions due to repeated CSF sampling through the Ommaya Reservoir.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing to have brain surgery at Mayo Clinic in Rochester, MN.
Select...
I am older than 18 years.
Select...
I am scheduled for brain surgery to remove a tumor.
Select...
I have signs and scans indicating a brain tumor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, approximately 42 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, approximately 42 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events of intra-operative Ommaya Reservoir placement
Intra-operative Ommaya Reservoir placement

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ommaya Reservoir placementExperimental Treatment1 Intervention
Subjects undergoing surgery for a confirmed or suspected brain tumor will have an Ommaya Reservoir placed at the time of surgery.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,729 Previous Clinical Trials
40,965,864 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,251 Previous Clinical Trials
3,785,358 Total Patients Enrolled
Terry C Burns, MD, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
310 Total Patients Enrolled

Media Library

Intra-operative Ommaya Reservoir placement (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04692337 — N/A
Brain Tumor Research Study Groups: Ommaya Reservoir placement
Brain Tumor Clinical Trial 2023: Intra-operative Ommaya Reservoir placement Highlights & Side Effects. Trial Name: NCT04692337 — N/A
Intra-operative Ommaya Reservoir placement (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04692337 — N/A
~12 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top